N
ARRY

Natixis’s Array Biopharma Inc ARRY Stock Holding History

Natixis’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-153,536
Closed -$7.11M – 969
2019
Q2 		$7.11M Buy
+153,536
New +$4.31M 0.05% 267

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Natixis's ARRY Position: Q3 2019 in Review

Natixis sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 153,536 shares — an estimated $7.11M sold.

Natixis first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $7.11M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Natixis reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Natixis sold 153,536 Array Biopharma Inc shares in Q3 2019, an estimated $7.11M.
  • Natixis first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Natixis's Array Biopharma Inc position peaked at $7.11M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Natixis's 13F filing for Q3 2019, filed 13 Nov 2019.